$HOV
HOVNANIAN ENTERPRISES INC

2019 Q2 Form 10-Q Financial Statement

#000143774919011566 Filed on June 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q2
Revenue $440.7M
YoY Change -12.31%
Cost Of Revenue $370.8M
YoY Change -10.65%
Gross Profit $69.90M
YoY Change -20.11%
Gross Profit Margin 15.86%
Selling, General & Admin $60.30M
YoY Change -2.27%
% of Gross Profit 86.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $900.0K
YoY Change 28.57%
% of Gross Profit 1.29%
Operating Expenses $60.70M
YoY Change -2.41%
Operating Profit $9.200M
YoY Change -63.64%
Interest Expense -$24.10M
YoY Change -28.06%
% of Operating Profit -261.96%
Other Income/Expense, Net
YoY Change
Pretax Income -$14.91M
YoY Change 55.69%
Income Tax $345.0K
% Of Pretax Income
Net Earnings -$15.26M
YoY Change 55.32%
Net Earnings / Revenue -3.46%
Basic Earnings Per Share -$2.56
Diluted Earnings Per Share -$2.56
COMMON SHARES
Basic Shares Outstanding 5.962M
Diluted Shares Outstanding 5.962M

Balance Sheet

Concept 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $124.0M
YoY Change -51.14%
Cash & Equivalents $168.6M
Short-Term Investments
Other Short-Term Assets $41.10M
YoY Change 1.48%
Inventory $1.268B
Prepaid Expenses
Receivables $29.20M
Other Receivables $0.00
Total Short-Term Assets $1.462B
YoY Change 4.12%
LONG-TERM ASSETS
Property, Plant & Equipment $20.30M
YoY Change 2.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $135.6M
YoY Change 53.57%
Other Assets $17.20M
YoY Change 22.86%
Total Long-Term Assets $292.9M
YoY Change 23.06%
TOTAL ASSETS
Total Short-Term Assets $1.462B
Total Long-Term Assets $292.9M
Total Assets $1.755B
YoY Change 6.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $131.7M
YoY Change 12.85%
Accrued Expenses $43.80M
YoY Change 6.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $215.5M
YoY Change 13.0%
LONG-TERM LIABILITIES
Long-Term Debt $1.691B
YoY Change 1.38%
Other Long-Term Liabilities $333.2M
YoY Change 17.45%
Total Long-Term Liabilities $2.024B
YoY Change 3.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $215.5M
Total Long-Term Liabilities $2.024B
Total Liabilities $2.240B
YoY Change 4.54%
SHAREHOLDERS EQUITY
Retained Earnings -$1.217B
YoY Change -1.01%
Common Stock $711.5M
YoY Change 0.57%
Preferred Stock
YoY Change
Treasury Stock (at cost) $115.4M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$485.0M
YoY Change
Total Liabilities & Shareholders Equity $1.755B
YoY Change 6.87%

Cashflow Statement

Concept 2019 Q2
OPERATING ACTIVITIES
Net Income -$15.26M
YoY Change 55.32%
Depreciation, Depletion And Amortization $900.0K
YoY Change 28.57%
Cash From Operating Activities -$76.70M
YoY Change -535.8%
INVESTING ACTIVITIES
Capital Expenditures -$1.000M
YoY Change -23.08%
Acquisitions
YoY Change
Other Investing Activities -$6.400M
YoY Change -220.75%
Cash From Investing Activities -$7.300M
YoY Change -282.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 99.40M
YoY Change -429.14%
NET CHANGE
Cash From Operating Activities -76.70M
Cash From Investing Activities -7.300M
Cash From Financing Activities 99.40M
Net Change In Cash 15.40M
YoY Change -279.07%
FREE CASH FLOW
Cash From Operating Activities -$76.70M
Capital Expenditures -$1.000M
Free Cash Flow -$75.70M
YoY Change -500.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 hov Aggregate Retention For Construction Defects Warranty And Bodily Injury Claims
AggregateRetentionForConstructionDefectsWarrantyAndBodilyInjuryClaims
20000000
CY2018Q2 hov Aggregate Retention For Construction Defects Warranty And Bodily Injury Claims
AggregateRetentionForConstructionDefectsWarrantyAndBodilyInjuryClaims
20000000
CY2019Q2 hov Bodily Injury Insurance Deductible
BodilyInjuryInsuranceDeductible
250000
CY2018Q2 hov Bodily Injury Insurance Deductible
BodilyInjuryInsuranceDeductible
250000
CY2019Q2 hov Bodily Injury Insurance Limit
BodilyInjuryInsuranceLimit
5000000
CY2018Q2 hov Bodily Injury Insurance Limit
BodilyInjuryInsuranceLimit
5000000
hov Carrying Value Of Communities Tested For Impairment
CarryingValueOfCommunitiesTestedForImpairment
51600000
hov Carrying Value Of Communities Tested For Impairment
CarryingValueOfCommunitiesTestedForImpairment
11200000
hov Cash Received From Subcontractors For Owner Controlled Insurance Program
CashReceivedFromSubcontractorsForOwnerControlledInsuranceProgram
2200000
hov Cash Received From Subcontractors For Owner Controlled Insurance Program
CashReceivedFromSubcontractorsForOwnerControlledInsuranceProgram
1900000
CY2019Q2 hov Changes In Noncontrolling Interest In Consolidated Joint Ventures
ChangesInNoncontrollingInterestInConsolidatedJointVentures
566000
CY2019Q2 hov Common Stock Dividends Percent Of Increase From Class A To Class B
CommonStockDividendsPercentOfIncreaseFromClassAToClassB
1.1
hov Conversion Of Stock From Class B To Class A Conversion Ratio
ConversionOfStockFromClassBToClassAConversionRatio
1
CY2019Q1 hov Conversion Of Stock Value
ConversionOfStockValue
CY2019Q2 hov Conversion Of Stock Value
ConversionOfStockValue
CY2018Q2 hov Conversion Of Stock Value
ConversionOfStockValue
CY2019Q2 hov Corporate General And Administrative
CorporateGeneralAndAdministrative
16169000
CY2018Q2 hov Corporate General And Administrative
CorporateGeneralAndAdministrative
16144000
hov Corporate General And Administrative
CorporateGeneralAndAdministrative
33833000
hov Corporate General And Administrative
CorporateGeneralAndAdministrative
35279000
CY2019Q2 hov Debt Covenant Fixed Charge Coverage Ratio Minimum
DebtCovenantFixedChargeCoverageRatioMinimum
2
CY2019Q2 hov Deposits Associated With Land And Lot Options Of Unconsolidated Variable Interest Entities
DepositsAssociatedWithLandAndLotOptionsOfUnconsolidatedVariableInterestEntities
69200000
CY2019Q2 hov General Liability Insurance Deductible
GeneralLiabilityInsuranceDeductible
20000000
CY2018Q2 hov General Liability Insurance Deductible
GeneralLiabilityInsuranceDeductible
20000000
hov Inventory Impairments And Land Option Cost Write Offs
InventoryImpairmentsAndLandOptionCostWriteOffs
2166000
hov Inventory Impairments And Land Option Cost Write Offs
InventoryImpairmentsAndLandOptionCostWriteOffs
3087000
CY2018Q2 hov Joint Venture Total Debt To Capitalization Ratio
JointVentureTotalDebtToCapitalizationRatio
0.45
CY2019Q2 hov Loans Held For Sale Mortgages Unpaid Principal
LoansHeldForSaleMortgagesUnpaidPrincipal
88300000
CY2018Q4 hov Loans Held For Sale Mortgages Unpaid Principal
LoansHeldForSaleMortgagesUnpaidPrincipal
127600000
hov Noncontrolling Interest Income In Consolidated Joint Venture
NoncontrollingInterestIncomeInConsolidatedJointVenture
28000
hov Noncontrolling Interest Income In Consolidated Joint Venture
NoncontrollingInterestIncomeInConsolidatedJointVenture
hov Number Of Communities Evaluated For Impairment
NumberOfCommunitiesEvaluatedForImpairment
398
hov Number Of Communities Evaluated For Impairment
NumberOfCommunitiesEvaluatedForImpairment
377
hov Number Of Communities Performed Detailed Impairment Calculations
NumberOfCommunitiesPerformedDetailedImpairmentCalculations
6
hov Number Of Communities Performed Detailed Impairment Calculations
NumberOfCommunitiesPerformedDetailedImpairmentCalculations
5
CY2019Q2 hov Number Of Loans Reserved For
NumberOfLoansReservedFor
20
CY2018Q2 hov Number Of Loans Reserved For
NumberOfLoansReservedFor
45
CY2019Q2 hov Payments By Insurance Companies For Claims
PaymentsByInsuranceCompaniesForClaims
100000
hov Payment Of Financing Costs For Debt Issuance And Land Bank Financing
PaymentOfFinancingCostsForDebtIssuanceAndLandBankFinancing
3962000
hov Payment Of Financing Costs For Debt Issuance And Land Bank Financing
PaymentOfFinancingCostsForDebtIssuanceAndLandBankFinancing
5523000
CY2019Q2 us-gaap Assets
Assets
1755272000
hov Payments By Insurance Companies For Claims
PaymentsByInsuranceCompaniesForClaims
100000
CY2018Q2 hov Payments By Insurance Companies For Claims
PaymentsByInsuranceCompaniesForClaims
100000
hov Payments By Insurance Companies For Claims
PaymentsByInsuranceCompaniesForClaims
100000
hov Payments For Land Bank Financing Program
PaymentsForLandBankFinancingProgram
8765000
hov Payments For Land Bank Financing Program
PaymentsForLandBankFinancingProgram
19890000
hov Payments For Model Sale Leaseback Financing Programs
PaymentsForModelSaleLeasebackFinancingPrograms
6627000
hov Payments For Model Sale Leaseback Financing Programs
PaymentsForModelSaleLeasebackFinancingPrograms
22741000
CY2019Q2 hov Payments Settlements
PaymentsSettlements
CY2018Q2 hov Payments Settlements
PaymentsSettlements
hov Payments Settlements
PaymentsSettlements
-1350000
hov Payments Settlements
PaymentsSettlements
hov Proceeds From Land Bank Financing Program
ProceedsFromLandBankFinancingProgram
61155000
hov Proceeds From Land Bank Financing Program
ProceedsFromLandBankFinancingProgram
3766000
hov Proceeds From Model Sale Leaseback Financing Programs
ProceedsFromModelSaleLeasebackFinancingPrograms
14905000
hov Proceeds From Model Sale Leaseback Financing Programs
ProceedsFromModelSaleLeasebackFinancingPrograms
746000
CY2019Q2 hov Purchase Price Associated With Land And Lot Options Of Unconsolidated Variable Interest Entities
PurchasePriceAssociatedWithLandAndLotOptionsOfUnconsolidatedVariableInterestEntities
1300000000
CY2019Q2 hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
22663000
CY2018Q2 hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
26088000
hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
44936000
hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
55219000
CY2008Q3 hov Shareholder Ownership Percentage Of Increase
ShareholderOwnershipPercentageOfIncrease
0.5
CY2019Q1 hov Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value
StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue
485000
CY2019Q2 hov Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value
StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue
468000
CY2018Q1 hov Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value
StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue
-219000
CY2018Q2 hov Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value
StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue
944000
CY2019Q1 hov Stock Options Amortization And Issuance Value
StockOptionsAmortizationAndIssuanceValue
107000
CY2019Q2 hov Stock Options Amortization And Issuance Value
StockOptionsAmortizationAndIssuanceValue
108000
CY2018Q1 hov Stock Options Amortization And Issuance Value
StockOptionsAmortizationAndIssuanceValue
210000
CY2018Q2 hov Stock Options Amortization And Issuance Value
StockOptionsAmortizationAndIssuanceValue
92000
CY2019Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
2090000
CY2018Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
3334000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
711517000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
710349000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1200000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2100000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4150000
CY2019Q2 us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
-32000
CY2018Q2 us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
45000
us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
-22000
us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
45000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3880000
CY2018Q4 us-gaap Assets
Assets
1662042000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
232992000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
493742000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
168603000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
292891000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-64389000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-200851000
CY2019Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
121700000
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
199600000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
462855000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
512025000
us-gaap Costs And Expenses
CostsAndExpenses
870117000
us-gaap Costs And Expenses
CostsAndExpenses
954486000
CY2019Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1213335000
CY2018Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1268959000
CY2019Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
13000000
CY2018Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
14100000
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
642900000
us-gaap Depreciation
Depreciation
1938000
us-gaap Depreciation
Depreciation
1509000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: top;"> <td style="width: 18pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18.</div></div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Recent Accounting Pronouncements</div></div> </td> </tr> </table> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 45pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;Revenue from Contracts with Customers&#x201d; (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>), (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> requires entities to recognize revenue that represents the transfer of promised goods or services to customers in an amount equivalent to the consideration to which the entity expects to be entitled to in exchange for those goods or services. The following steps should be applied to determine this amount: (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) identify the contract(s) with a customer; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) identify the performance obligations in the contract; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) determine the transaction price; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>) allocate the transaction price to the performance obligations in the contract; and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>) recognize revenue when (or as) the entity satisfies a performance obligation. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> supersedes the revenue recognition requirements in ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605,</div> &#x201c;Revenue Recognition,&#x201d; and most industry-specific guidance in the Accounting Standards Codification. The FASB has also issued a number of updates to this standard. The standard was effective for us for annual and interim periods beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 1, 2018 </div>and we applied the modified retrospective method of adoption. The implementation did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> result in any significant changes to our business processes, systems, or internal controls, or have a material impact on our Condensed Consolidated Financial Statements.&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 45pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 45pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>)&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02&#x201d;</div>), which provides guidance for accounting for leases. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> requires lessees to classify leases as either finance or operating leases and to record a right-of-use asset and a lease liability for all leases with a term greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized based on an effective interest rate method or on a straight line basis over the term of the lease. Accounting for lessors remains largely unchanged from current GAAP. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> is effective for the Company beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 1, 2019. </div>Early adoption is permitted. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> &#x201c;Codification Improvements to Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842,</div> Leases&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10&#x201d;</div>) and ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div> &#x201c;Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>) Targeted Improvements&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11&#x201d;</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> provides certain amendments that affect narrow aspects of the guidance issued in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02.</div> ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div> allows all entities adopting ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> to choose an additional (and optional) transition method of adoption, under which an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div> also allows lessors to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> separate nonlease components from the associated&nbsp;lease component if certain conditions are met. We are currently evaluating both the method and the impact of adopting this guidance on our Condensed Consolidated Financial Statements.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 45pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;Codification Improvements&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> provides amendments to a wide variety of topics in the FASB&#x2019;s Accounting Standards Codification, which applies to all reporting entities within the scope of the affected accounting guidance. The transition and effective date guidance are&nbsp;based on the facts and circumstances of each amendment. Some of the amendments in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require transition guidance and were&nbsp;effective upon issuance of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div> However, many of the amendments do have transition guidance with effective dates for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018. </div>We are currently evaluating the potential impact of adopting the applicable guidance on our Condensed Consolidated Financial Statements.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 45pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2018, </div>the FASB issued&nbsp;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,</div> &#x201c;Fair Value Measurement (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">820</div>) - Disclosure Framework&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13&#x201d;</div>), which improves the disclosure requirements for fair value measurements. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> is effective for us beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div> Early adoption is permitted for any removed or modified disclosures. We are currently evaluating the potential impact of adopting this guidance on our Condensed Consolidated Financial Statements.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 45pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> &#x201c;Intangibles-Goodwill and Other-Internal-Use Software (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40</div>): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15&#x201d;</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> is effective for us beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 1, 2020. </div>Early adoption is permitted. We are&nbsp;currently evaluating the potential impact of adopting this guidance on our Condensed Consolidated Financial Statements.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"></div></div>
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.56
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.65
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.49
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.85
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6917000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
CY2018Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
13000000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
12000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3592000
CY2017Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-42300000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1440000
CY2019Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2018Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1440000
CY2019Q2 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
1000000
CY2018Q2 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
2100000
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
1000000
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
2100000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50200000
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48100000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8100000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14912000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9578000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32018000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40049000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
16814000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3833000
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7252000
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1343000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
345000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
691000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
245000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
583000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1936000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
909000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-24119000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-46511000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1244000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
7867000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-2775000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-325000
CY2019Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
19776000
CY2018Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
23448000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2299000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3302000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
192059000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20267000
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-474457000
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-501227000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4712000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
16349000
CY2019Q2 us-gaap Interest Paid
InterestPaid
514000
CY2018Q2 us-gaap Interest Paid
InterestPaid
585000
us-gaap Interest Paid
InterestPaid
1203000
us-gaap Interest Paid
InterestPaid
1186000
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
3401000
CY2018Q2 us-gaap Interest Paid Net
InterestPaidNet
3225000
us-gaap Interest Paid Net
InterestPaidNet
43840000
us-gaap Interest Paid Net
InterestPaidNet
59707000
CY2019Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
37900000
CY2018Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
35600000
CY2019Q2 us-gaap Liabilities
Liabilities
2239751000
CY2018Q4 us-gaap Liabilities
Liabilities
2115546000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1755272000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1662042000
CY2019Q2 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
78800000
CY2018Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
115200000
CY2019Q2 us-gaap Minority Interest
MinorityInterest
566000
CY2018Q4 us-gaap Minority Interest
MinorityInterest
CY2019Q1 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
1264000
CY2018Q1 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
3188000
CY2018Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
2563000
CY2017Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
3158000
CY2019Q2 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
1269000
CY2018Q2 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
3271000
CY2019Q2 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
91249000
CY2018Q4 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
130694000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
138391000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-175833000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3911000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
44940000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-198869000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-69958000
CY2019Q2 us-gaap Other Commitment
OtherCommitment
18000000
CY2019Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-329000
CY2018Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-402000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-571000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-792000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
435012000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
456828000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
7727000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
18879000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1956000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3208000
CY2019Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
140000000
CY2018Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
140000000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5600
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5600
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5600
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5600
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
135299000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
135299000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Reclassifications - Effective October 31, 2018 we early adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-18 &#x201c;Statement of Cash Flows (Topic 230): Restricted Cash&#x201d; (&#x201c;ASU 2016-18&#x201d;). As a result, restricted cash amounts are no longer shown within the operating and investing activities as these balances are now included in the beginning and ending cash balances in our Condensed Consolidated Statements of Cash Flows. The adoption of ASU 2016-18 also resulted in the reclassification of restricted cash in operating and investing activities of $2.6 million and $12.1 million, respectively, for the six months ended April 30, 2018. These amounts are now included in the beginning and ending cash balances for the respective periods. See also the reconciliation of cash, cash equivalents and restricted cash on the Condensed Consolidated Statements of Cash Flows.</div></div></div></div></div>
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
5756000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
28754000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
594000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
171045000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
75962000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-36606000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-43439000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
16000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
38273000
us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
21348000
us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
132500000
CY2019Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
93410000
CY2018Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
129314000
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
95064000
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
127702000
CY2019Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
92849000
CY2018Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
115775000
CY2019Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4020000
CY2018Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
19862000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
10111000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
26164000
CY2019Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
192000
CY2018Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
443000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
us-gaap Profit Loss
ProfitLoss
-32709000
us-gaap Profit Loss
ProfitLoss
-40632000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-15257000
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-9823000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-17452000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-30809000
CY2019Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
37000
CY2018Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
38000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
78000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
68000
CY2019Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
74455000
CY2018Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
70793000
CY2018Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
68117000
CY2017Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
71051000
CY2019Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
79277000
CY2018Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
65355000
CY2019Q2 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
13898000
CY2018Q2 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
19364000
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
24140000
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
31656000
CY2019Q2 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
41383000
CY2018Q2 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
40014000
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
80236000
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
81179000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
74696000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
82121000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
215093000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1216565000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1183856000
CY2019Q2 us-gaap Revenues
Revenues
440691000
CY2018Q2 us-gaap Revenues
Revenues
502544000
us-gaap Revenues
Revenues
821285000
us-gaap Revenues
Revenues
919710000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
115360000
us-gaap Share Based Compensation
ShareBasedCompensation
1191000
us-gaap Share Based Compensation
ShareBasedCompensation
2075000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-485045000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-453504000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-484479000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-453504000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-470364000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-460371000
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-491189000
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-499976000
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
115360000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5962000
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5937000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5960000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5929000

Files In Submission

Name View Source Status
0001437749-19-011566-index-headers.html Edgar Link pending
0001437749-19-011566-index.html Edgar Link pending
0001437749-19-011566.txt Edgar Link pending
0001437749-19-011566-xbrl.zip Edgar Link pending
ex_146385.htm Edgar Link pending
ex_146386.htm Edgar Link pending
ex_146387.htm Edgar Link pending
ex_146388.htm Edgar Link pending
ex_146397.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hov-20190430.xml Edgar Link completed
hov-20190430.xsd Edgar Link pending
hov-20190430_cal.xml Edgar Link unprocessable
hov-20190430_def.xml Edgar Link unprocessable
hov-20190430_lab.xml Edgar Link unprocessable
hov-20190430_pre.xml Edgar Link unprocessable
hov20190430_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending